Foreign firms deny wrongdoing as Indian ministry points to trials 'deficiencies'
This article was originally published in Scrip
Executive Summary
In its recent affidavit in an ongoing legal case concerning clinical trials, India's health ministry refers to certain past lapses of large companies including Pfizer, Sanofi and the contract services provider Quintiles in studies conducted at the Bhopal Memorial Hospital and Research Centre (BMHRC), although the firms involved strongly deny any wrongdoing.